PROSTATE CANCER: Benefit and safety of adjuvant radiation therapy

    loading  Checking for direct PDF access through Ovid

Abstract

10-year data from the European Organisation for Research and Treatment of Cancer trial 22911 have been published, reigniting the debate regarding postoperative radiotherapy for prostate cancer. These data show that adjuvant radiotherapy significantly improves biochemical progression-free survival and local control compared with a ‘wait-and-see’ policy, supporting the 5-year follow-up data.

Related Topics

    loading  Loading Related Articles